Early Administration of Dapagliflozin Preserves Pancreatic Beta-Cell Mass Through a Legacy Effect in Type 2 Diabetic Mice

Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.12945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Epigenetic Aspects of Pancreatic Beta Cell Function in Type 2 Diabetes

Archives of Public Health
EnvironmentalPublic HealthOccupational Health
2014English

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic -Cell Mass and Function in a Rodent Model of Type 2 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Pancreatic Beta Cell/Islet Mass and Body Mass Index

Islets
EndocrinologyMetabolismDiabetes
2019English

Pancreatic Alpha Cell Mass in European Subjects With Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Vascular Endothelial PDPK1 Plays a Pivotal Role in the Maintenance of Pancreatic Beta Cell Mass and Function in Adult Male Mice

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Administration of CORM-2 Inhibits Diabetic Neuropathy but Does Not Reduce Dyslipidemia in Diabetic Mice

PLoS ONE
Multidisciplinary
2018English

Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2012English

A Euglycaemic/Non-Diabetic Perinatal Environment Does Not Alleviate Early Beta Cell Maldevelopment and Type 2 Diabetes Risk in the GK/Par Rat Model

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Islet Amyloid Polypeptide in Pancreatic Islets From Type 2 Diabetic Subjects

Islets
EndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy